Chronic Myeloproliferative Neoplasms: Some Remaining Challenges

Chronic Myeloproliferative Neoplasms: Some Remaining Challenges

Bibliographic Details
Main Authors:	Tariq I. Mughal, Giuseppe Saglio, Richard A. Van Etten
Format:	Article
Language:	English
Published:	Wolters Kluwer 2018-10-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/HS9.0000000000000147

Similar Items

Children and Adolescents with Chronic Myeloproliferative Neoplasms: Still an Unmet Biological and Clinical Need?
by: Tariq I. Mughal, et al.
Published: (2019-10-01)

Secondary acute leukemia evolving from myeloproliferative neoplasm (MPN)
by: Tariq Mughal
Published: (2020-10-01)

Philadelphia-negative chronic myeloproliferative neoplasms
by: Rosane Isabel Bittencourt, et al.
Published: (2012-01-01)

Challenges and Perspectives for Therapeutic Targeting of Myeloproliferative Neoplasms
by: Sime Brkic, et al.
Published: (2021-01-01)

CHRONIC MYELOPROLIFERATIVE NEOPLASMS: A COLLABORATIVE APPROACH
by: Paola Guglielmelli, et al.
Published: (2010-05-01)

CHRONIC MYELOPROLIFERATIVE NEOPLASMS: A COLLABORATIVE APPROACH
by: Lisa Pieri, et al.
Published: (2010-06-01)

Coexistence of Chronic Lymphocytic Leukemia and Myeloproliferative Neoplasm
by: Patrycja Zielinska, et al.
Published: (2014-01-01)

Platelets as Mediators of Thromboinflammation in Chronic Myeloproliferative Neoplasms
by: Cecilia P. Marin Oyarzún, et al.
Published: (2019-06-01)

Aetiology of Myeloproliferative Neoplasms
by: Mary Frances McMullin, et al.
Published: (2020-07-01)

Emerging Role of Neutrophils in the Thrombosis of Chronic Myeloproliferative Neoplasms
by: Francisca Ferrer-Marín, et al.
Published: (2021-01-01)

Pathogenesis of Myeloproliferative Neoplasms: Role and Mechanisms of Chronic Inflammation
by: Sylvie Hermouet, et al.
Published: (2015-01-01)

Study of intracellular signaling pathways in Chronic Myeloproliferative Neoplasms
Published: (2017)

The Role of New Technologies in Myeloproliferative Neoplasms
by: Giuseppe A. Palumbo, et al.
Published: (2019-04-01)

Molecular pathogenesis of the myeloproliferative neoplasms
by: Graeme Greenfield, et al.
Published: (2021-06-01)

Targeted therapies for myeloproliferative neoplasms
by: Bing Li, et al.
Published: (2019-07-01)

Novel therapeutics in myeloproliferative neoplasms
by: Sangeetha Venugopal, et al.
Published: (2020-12-01)

Mutant Calreticulin in the Myeloproliferative Neoplasms
by: Daniel Prins, et al.
Published: (2020-02-01)

Neurological Findings in Myeloproliferative Neoplasms
by: Semra Paydas
Published: (2013-04-01)

Experimental Modeling of Myeloproliferative Neoplasms
by: Lucie Lanikova, et al.
Published: (2019-10-01)

Calreticulin Mutations in Myeloproliferative Neoplasms
by: Noa Lavi
Published: (2014-10-01)

CALR Mutations in Myeloproliferative Neoplasms
by: Ken-Hong Lim
Published: (2014-06-01)

The Hematopoietic Niche in Myeloproliferative Neoplasms
by: Annette H. Schmitt-Graeff, et al.
Published: (2015-01-01)

Vascular Diseases In Patients With Chronic Myeloproliferative Neoplasms – Impact Of Comorbidity
by: Frederiksen H, et al.
Published: (2019-11-01)

The JAK2 gene as a protagonist in chronic myeloproliferative neoplasms
by: Renata Mendes de Freitas, et al.
Published: (2013-01-01)

Defining the Thrombotic Risk in Patients with Myeloproliferative Neoplasms
by: Fabrizio Vianello, et al.
Published: (2011-01-01)

Clonal Hematopoiesis and Mutations of Myeloproliferative Neoplasms
by: Lasse Kjær
Published: (2020-07-01)

Cytokines frequently implicated in myeloproliferative neoplasms
by: Yingying Wang, et al.
Published: (2019-03-01)

NK Cells in Myeloproliferative Neoplasms (MPN)
by: Erin Naismith, et al.
Published: (2021-08-01)

Genetic Aspects of Myelodysplastic/Myeloproliferative Neoplasms
by: Laura Palomo, et al.
Published: (2021-04-01)

Functional Consequences of Mutations in Myeloproliferative Neoplasms
by: Stefan N. Constantinescu, et al.
Published: (2021-06-01)

The Roles of Calreticulin Mutations in Myeloproliferative Neoplasms
by: Ken-Hong Lim, et al.
Published: (2017)

Comparison and Implications of Mutational Profiles of Myelodysplastic Syndromes, Myeloproliferative Neoplasms, and Myelodysplastic/Myeloproliferative Neoplasms: A Meta-Analysis
by: Ziqi Wan, et al.
Published: (2020-10-01)

THE ROLE OF JAK2 MUTATION IN THROMBOTIC COMPLICATIONS OF CHRONIC MYELOPROLIFERATIVE NEOPLASMS
by: Viola M. Popov, et al.
Published: (2014-08-01)

JAK2 exon 14 deletion in patients with chronic myeloproliferative neoplasms.
by: Wanlong Ma, et al.
Published: (2010-01-01)

Cancer Immune Therapy for Philadelphia Chromosome-Negative Chronic Myeloproliferative Neoplasms
by: Morten Orebo Holmström, et al.
Published: (2020-07-01)

Molecular approach to diagnose BCR/ABL negative chronic myeloproliferative neoplasms
by: Michelle Maccarini Barcelos, et al.
Published: (2011-01-01)

Thrombosis in patients with myeloproliferative neoplasms. Case report
by: Anait L. Melikyan, et al.
Published: (2021-07-01)

The Prognostic Role of Cytogenetics Analysis in Philadelphia Negative Myeloproliferative Neoplasms
by: Giuseppe Lanzarone, et al.
Published: (2021-08-01)

Impact of Inflammation on Myeloproliferative Neoplasm Symptom Development
by: Holly L. Geyer, et al.
Published: (2015-01-01)

Granulocytic sarcoma: Extramedullary manifestation of chronic myeloproliferative neoplasm in a young African woman
by: Ajayi A. Ibijola, et al.
Published: (2021-03-01)